Understanding medication nonadherence after kidney transplant

Journal of the American Society of Nephrology

Volumn 28, Issue 8, 2017, Pages 2290-2301

  Nevins, Thomas E ^a   Nickerson, Peter W ^b   Dew, Mary Amanda ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIRECTLY OBSERVED THERAPY; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE SYSTEM; HUMAN; INTERVENTION STUDY; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MEDICATION COMPLIANCE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUANTITATIVE STUDY; REVIEW; RISK FACTOR; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

IMMUNOSUPPRESSIVE AGENT;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MEDICATION ADHERENCE; RISK FACTORS;

EID: 85026545200     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2017020216     Document Type: Review

References (69)

1. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4: 378-383, 2004
2. Lamb KE, Lodhi S, Meier-KriescheH-U: Longterm renal allograft survival in the United States: A critical reappraisal. Am J Transplant 11: 450-462, 2011
3. Ekberg H, Tedesco-Silva H, Demirbas A, Vítko S, Nashan B, Gürkan A, Margreiter R, Hugo C, Grinyó JM, Frei U, Vanrenterghem Y, Daloze P, Halloran PF; ELITE-Symphony Study: Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 357: 2562-2575, 2007
4. Wiebe C, Gibson IW, Blydt-Hansen TD, Pochinco D, Birk PE, Ho J, Karpinski M, Goldberg A, Storsley L, Rush DN, Nickerson PW: Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody. Am J Transplant 15: 2921-2930, 2015
5. Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, Goldberg A, Birk PE, Rush DN, Nickerson PW: Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 12: 1157-1167, 2012
6. Wiebe C, Nickerson P: Strategic use of epitope matching to improve outcomes. Transplantation 100: 2048-2052, 2016
7. The Steering Committee of the Physicians' Health Study Research Group: Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 318: 262-264, 1988
8. Clyne W, McLachlan S, Mshelia C, Jones P, De Geest S, Ruppar T, Siebens K, Dobbels F, Kardas P: "My patients are better than yours": Optimistic bias about patients' medication adherence by European health care professionals. Patient Prefer Adherence 10: 1937-1944, 2016
9. Nevins TE, Kruse L, Skeans MA, Thomas W: The natural history of azathioprine compliance after renal transplantation. Kidney Int 60: 1565-1570, 2001
10. Modi AC, Rausch JR, Glauser TA: Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA 305: 1669-1676, 2011
11. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M: Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories. BMJ 336: 1114-1117, 2008
12. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24: 67-74, 1986
13. Sackett DL: Hypertension in the real world: Public reaction, physician response, and patient compliance. In: Hypertension: Pathophysiology and Treatment, edited byGenest J, Kevin E, Kechel P, New York, McGraw-Hill, 1977, p 1142
14. Nevins TE, Thomas W:Quantitative patterns of azathioprine adherence after renal transplantation. Transplantation 87: 711-718, 2009
15. Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J: Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension 62: 218-225, 2013
16. Fine RN, Becker Y, De Geest S, Eisen H, Ettenger R, Evans R, Rudow DL, McKay D, Neu A, Nevins T, Reyes J, Wray J, Dobbels F: Nonadherence consensus conference summary report. Am J Transplant 9: 35-41, 2009
17. Glass TR, De Geest S, Hirschel B, Battegay M, Furrer H, Covassini M, Vernazza PL, Bernasconi E, Rickenboch M, Weber R, Bucher HC; Swiss HIV Cohort Study: Selfreported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antivir Ther 13: 77-85, 2008
18. Modi AC, Ingerski LM, Rausch JR, Glauser TA, Drotar D:White coat adherence over the first year of therapy in pediatric epilepsy. J Pediatr 161: 695-9.e1, 2012
19. Hsiau M, Fernandez HE, Gjertson D, Ettenger RB, Tsai EW: Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation. Transplantation 92: 918-922, 2011
20. Sapir-Pichhadze R, Wang Y, Famure O, Li Y, Kim SJ: Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure. Kidney Int 85: 1404-1411, 2014
21. Vanhove T, Vermeulen T, Annaert P, Lerut E, Kuypers DRJ: High intrapatient variability of tacrolimus concentrations predicts accelerated progression of chronic histologic lesions in renal recipients. Am J Transplant 16: 2954-2963, 2016
22. US Food and Drug Administration: Draft Guidance for Industry Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products, December 2012. Available at: www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/ guidances/ucm332181.pdf. Accessed February 27, 2017
23. Nevins TE, Robiner WN, Thomas W:Predictive patterns of early medication adherence in renal transplantation. Transplantation 98: 878-884, 2014
24. Sabaté E, World Health Organization: Adherence to Long-Term Therapies: Evidence for Action, Geneva, Switzerland, World Health Organization, 2003
25. Denhaerynck K, Dobbels F, Cleemput I, Desmyttere A, Schäfer-Keller P, Schaub S, De Geest S: Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: A literature review. Transpl Int 18: 1121-1133, 2005
26. Prendergast MB, Gaston RS: Optimizing medication adherence: An ongoing opportunity to improve outcomes after kidney transplantation. Clin J Am Soc Nephrol 5: 1305-1311, 2010
27. Williams AF, Manias E, Gaskin CJ, Crawford K: Medicine non-adherence in kidney transplantation. J Ren Care 40: 107-116, 2014
28. Butler JA, Peveler RC, Roderick P, Smith PW, Horne R, Mason JC: Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: A cross-sectional study. Nephrol Dial Transplant 19: 3144-3149, 2004
29. Doyle IC, Maldonado AQ, Heldenbrand S, Tichy EM, Trofe-Clark J: Nonadherence to therapy after adult solid organ transplantation: A focus on risks and mitigation strategies. Am J Health Syst Pharm 73: 909-920, 2016
30. Neuberger JM, Bechstein WO, Kuypers DR, Burra P, Citterio F, De Geest S, Duvoux C, Jardine AG, Kamar N, Kramer BK, Metselaar HJ, Nevens F, Pirenne J, Rodriguez-Peralvarez ML, Samuel D, Schneeberger S, Seron D, Trunecka P, Tisone G, van Gelder T: Practical recommendations for long-termmanagement of modifiable risks in kidney and liver transplant recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group. Transplantation 101(4S Suppl 2): S1- S56, 2017
31. DeGeest S, Burkhalter H, Bogert L, Berben L, Glass TR, Denhaerynck K; Psychosocial Interest Group; Swiss Transplant Cohort Study: Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: The Swiss Transplant Cohort Study. Transpl Int 27: 657-666, 2014
32. Dew MA, DiMartini AF, De Vito Dabbs A, Myaskovsky L, Steel J, Unruh M, Switzer GE, Zomak R, Kormos RL, Greenhouse JB: Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 83: 858-873, 2007
33. Chisholm-Burns M, Pinsky B, Parker G, Johnson P, Arcona S, Buzinec P, Chakravarti P, Good M, Cooper M: Factors related to immunosuppressant medication adherence in renal transplant recipients. Clin Transplant 26: 706-713, 2012
34. Evans RW, Applegate WH, Briscoe DM, Cohen DJ, Rorick CC, Murphy BT, Madsen JC: Cost-related immunosuppressive medication nonadherence among kidney transplant recipients. Clin J Am Soc Nephrol 5: 2323-2328, 2010
35. Dew MA, Dabbs AD, Myaskovsky L, Shyu S, Shellmer DA, DiMartini AF, Steel J, Unruh M, Switzer GE, Shapiro R, Greenhouse JB: Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation 88: 736-746, 2009
36. Dobbels F, Ruppar T, De Geest S, Decorte A, Van Damme-Lombaerts R, Fine RN: Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: A systematic review. Pediatr Transplant 14: 603-613, 2010
37. Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR: Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 9: 2597-2606, 2009
38. Jamieson NJ, Hanson CS, Josephson MA, Gordon EJ, Craig JC, Halleck F, Budde K, Tong A: Motivations, challenges, and attitudes to self-management in kidney transplant recipients: A systematic review of qualitative studies. Am J Kidney Dis 67: 461-478, 2016
39. Tong A, Morton R, Howard K, Craig JC: Adolescent experiences following organ transplantation: A systematic review of qualitative studies. J Pediatr 155: 542-549, 2009
40. Tong A, Howell M, Wong G, Webster AC, Howard K, Craig JC: The perspectives of kidney transplant recipients on medicine taking: A systematic review of qualitative studies. Nephrol Dial Transplant 26: 344-354, 2011
41. Dew MA, DeVito Dabbs AJ: Harnessing the power of qualitative research in transplantation. Am J Kidney Dis 67: 357-359, 2016
42. Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT: Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clin Transplant 15: 330-336, 2001
43. Hardstaff R, Green K, Talbot D: Measurement of compliance posttransplantation- The results of a 12-month study using electronic monitoring. Transplant Proc 35: 796-797, 2003
44. DeGeest S, Schäfer-Keller P, Denhaerynck K, Thannberger N, Köfer S, Bock A, Surber C, Steiger J: Supporting medication adherence in renal transplantation (SMART): A pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant 20: 359-368, 2006
45. DeGeest S, Denhaerynck K, Schäfer-Keller P, Bock A, Steiger J: Supporting medication adherence in renal transplantation-The SMART study. Swiss Med Wkly 137[Suppl 155]: 125S-127S, 2007
46. Russell C, Conn V, Ashbaugh C, Madsen R, Wakefield M, Webb A, Coffey D, Peace L: Taking immunosuppressive medications effectively (TIMELink): A pilot randomized controlled trial in adult kidney transplant recipients. Clin Transplant 25: 864-870, 2011
47. Chisholm-Burns MA, Spivey CA, Graff Zivin J, Lee JK, Sredzinski E, Tolley EA: Improving outcomes of renal transplant recipients with behavioral adherence contracts: A randomized controlled trial. Am J Transplant 13: 2364-2373, 2013
48. Kuypers DRJ, Peeters PC, Sennesael JJ, Kianda MN, Vrijens B, Kristanto P, Dobbels F, Vanrenterghem Y, Kanaan N; ADMIRAD Study Team: Improved adherence to tacrolimus once-daily formulation in renal recipients: A randomized controlled trial using electronic monitoring. Transplantation 95: 333-340, 2013
49. Joost R, Dörje F, Schwitulla J, Eckardt KU, Hugo C: Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: A quasiexperimental study. Nephrol Dial Transplant 29: 1597-1607, 2014
50. Annunziato RA, Parbhakar M, Kapoor K, Matloff R, Casey N, Benchimol C, Hotchkiss H, Nair V, Saland J: Can transition to adult care for transplant recipients be improved by intensified services while patients are still in pediatrics? Prog Transplant 25: 236-242, 2015
51. Garcia MF, Bravin AM, Garcia PD, Contti MM, Nga HS, Takase HM, de Andrade LG: Behavioral measures to reduce non-adherence in renal transplant recipients: A prospective randomized controlled trial. Int Urol Nephrol 47: 1899-1905, 2015
52. Breu-Dejean N, Driot D, Dupouy J, Lapeyre-Mestre M, Rostaing L: Efficacy of psychoeducational intervention on allograft function in kidney transplant patients: 10-Year results of a prospective randomized study. Exp Clin Transplant 14: 38-44, 2016
53. Breu Dejean N, Rontaing L, Lapeyre-Mestre M, Roge B, Durang D: Educational Program to Reduce Noncompliance after Renal Transplantation, Abstract MO06. European Renal Association/European Dialysis and Transplantation Association, Archive of Congress Abstracts, 2004. Available at: http://www. abstracts2view.com/era-archive/view.php? nu=ERA4L-235. Accessed December 6, 2016
54. Henriksson J, Tydén G, Höijer J, Wadström J: A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation 100: 203-209, 2016
55. Cukor D, Ver Halen N, Pencille M, Tedla F, Salifu M: A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron 135: 6-14, 2017
56. Reese PP, Bloom RD, Trofe-Clark J, Mussell A, Leidy D, Levsky S, Zhu J, Yang L, Wang W, Troxel A, Feldman HI, Volpp K: Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: A randomized trial. AmJ Kidney Dis 69: 400-409, 2017
57. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd Ed., Hillsdale, NJ, Erlbaum, 1988
58. Dew MA, Goycoolea JM, Harris RC, Lee A, Zomak R, Dunbar-Jacob J, Rotondi A, Griffith BP, Kormos RL: An internet-based intervention to improve psychosocial outcomes in heart transplant recipients and family caregivers: Development and evaluation. J Heart Lung Transplant 23: 745-758, 2004
59. DeVito Dabbs A, Song MK, Myers BA, Li R, Hawkins RP, Pilewski JM, Bermudez CA, Aubrecht J, Begey A, Connolly M, Alrawashdeh M, Dew MA: A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation. Am J Transplant 16: 2172-2180, 2016
60. Klein A, Otto G, Krämer I: Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: A prospective, randomized, controlled trial using electronic monitoring. Transplantation 87: 839-847, 2009
61. Dobbels F, De Bleser L, Berben L, Kristanto P, Dupont L, Nevens F, Vanhaecke J, Verleden G, De Geest S: Efficacy of a medication adherence enhancing intervention in transplantation: The MAESTRO-Tx trial. J Heart Lung Transplant 36: 499-508, 2017
62. De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S: Interventions to improve medication-adherence after transplantation: A systematic review. Transpl Int 22: 780-797, 2009
63. Conn VS, Ruppar TM, Chase JAD, Enriquez M, Cooper PS: Interventions to improve medication adherence in hypertensive patients: Systematic review and meta-analysis. Curr Hypertens Rep 17: 94-109, 2015
64. Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, De Geest S, Dobbels F, Lewek P, Urquhart J, Vrijens B; ABC project team: Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: A systematic literature review and meta-analysis. Drugs 73: 545-562, 2013
65. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, Agoritsas T, Mistry N, Iorio A, Jack S, Sivaramalingam B, Iserman E, Mustafa RA, Jedraszewski D, Cotoi C, Haynes RB: Interventions for enhancing medication adherence. Cochrane Database Syst Rev 11: CD000011, 2014
66. Ruppar TM, Delgado JM, Temple J: Medication adherence interventions for heart failure patients: A meta-analysis. Eur J Cardiovasc Nurs 14: 395-404, 2015
67. Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 353: 487-497, 2005
68. Bosworth HB, Granger BB, Mendys P, Brindis R, Burkholder R, Czajkowski SM, Daniel JG, Ekman I, Ho M, Johnson M, Kimmel SE, Liu LZ, Musaus J, Shrank WH, Whalley Buono E, Weiss K, Granger CB: Medication adherence: A call for action. Am Heart J 162: 412-424, 2011
69. Wiebe C, Nevins TE, Robiner WN, Thomas W, Matas AJ, Nickerson PW: The synergistic effect of Class II HLA epitope-mismatch and nonadherence on acute rejection and graft survival. Am J Transplant 15: 2197-2202, 2015